89 / 89
89
82.
Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA,
Bordoni R, George S, et al. Efficacy of pamidronate in
reducing skeletal events in patients with advanced
multiple myeloma. Myeloma Aredia Study Group. N
Engl J Med 1996;334:488-93.
83.
Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA,
Bordoni R, George S, et al. Long-term pamidronate
treatment of advanced multiple myeloma patients
reduces skeletal events. Myeloma Aredia Study Group. J
Clin Oncol 1998;16:593-602.
84.
Morgan GJ, Child JA, Gregory WM, Szubert AJ, Cocks K,
Bell SE, et al. Effects of zoledronic acid versus clodronic
acid on skeletal morbidity in patients with newly
diagnosed multiple myeloma (MRC Myeloma IX):
secondary outcomes from a randomised controlled trial.
Lancet Oncol 2011;12:743-52.